Yseop
Yseop is a pioneering company in AI-powered automation for the life sciences industry, focusing on natural language generation (NLG) to accelerate regulatory and medical writing. Their platform, Yseop Copilot, is designed to reduce drafting time from weeks to minutes, ensure accuracy and compliance, and eliminate manual rework in critical documents like Clinical Study Reports (CSRs) and patient narratives. With a decade of experience before AI became mainstream, Yseop's technology is trusted by major pharmaceutical companies. They aim to transform document creation workflows, enabling faster submissions and bringing life-changing therapies to market more quickly. Their solutions also extend to finance and risk sectors, focusing on data insights and workflow modernization.
Yseop
Yseop is a pioneering company in AI-powered automation for the life sciences industry, focusing on natural language generation (NLG) to accelerate regulatory and medical writing. Their platform, Yseop Copilot, is designed to reduce drafting time from weeks to minutes, ensure accuracy and compliance, and eliminate manual rework in critical documents like Clinical Study Reports (CSRs) and patient narratives. With a decade of experience before AI became mainstream, Yseop's technology is trusted by major pharmaceutical companies. They aim to transform document creation workflows, enabling faster submissions and bringing life-changing therapies to market more quickly. Their solutions also extend to finance and risk sectors, focusing on data insights and workflow modernization.
TL;DR
Founded: 2007
Core product: Natural Language Generation for life-sciences regulatory and clinical documentation (Yseop Copilot)
Use case: Automating Clinical Study Reports, patient narratives, and submission-ready documents
Recent funding signal: Strategic investment including Novartis (Dec 5, 2023); other investors include Eli Lilly and Claret Capital Partners
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Regulatory and clinical documentation automation for life sciences; also applied to finance and risk sectors.
Founded
2007
Industry
Software Development
Tech Stack
Funding Track Record
Strategic investment round announced Dec 5, 2023
,000,000
Growth funding to scale generative AI platform (amount reported as M)
Investor Signal
“Includes strategic investors from pharma and finance such as Novartis (dRx Capital), Eli Lilly, NextStage AM, Wille Finance, and Claret Capital Partners”